Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
British Journal of Clinical Pharmacology|December 20, 2008
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological studyPål Gjerden, Jørgen G Bramness, Lars SlørdalEuropean Journal of Clinical Pharmacology|August 1, 2009
Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agentsPål Gjerden, Lars Slørdal, Jørgen G BramnessEuropean Journal of Clinical Pharmacology|June 4, 2010
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-upPål Gjerden, Lars Slørdal, Jørgen G BramnessBritish Journal of Clinical Pharmacology|August 22, 2009
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrinePål Gjerden, Lars Slørdal, Jørgen G BramnessEuropean Journal of Clinical Pharmacology|June 18, 2017
The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015Pål Gjerden, Jørgen G Bramness, Ingunn Fride Tvete, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2009
[Passive inhalation of cannabis smoke--is it detectable?]Andreas Austgulen Westin, Lars SlørdalTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2009
[Driving under the influence of amphetamine and metamphetamine]Kjersti Lia, Olav Spigset, Lars SlørdalTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 31, 2004
[Problem forte--is paracetamol-codeine combination rational?]Arne Helland, Olav Spigset, Lars SlørdalEuropean Journal of Clinical Pharmacology|March 20, 2010
Norwegian medical students' attitudes towards the pharmaceutical industryDordi Lea, Olav Spigset, Lars SlørdalPageof 6